Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

Clicks: 326
ID: 118951
1993
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The effects of passive respiratory syncytial virus (RSV) immune serum given as preinoculation prophylaxis, postinoculation prophylaxis, and as therapy on d 5 after inoculation were evaluated in an illness model of RSV infection in BALB/c mice. Pre- and postinoculation prophylaxis reduced RSV replica …
Reference Key
bs1993pediatricimmunoprophylaxis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Graham BS;Davis TH;Tang YW;Gruber WC;;
Journal Pediatric research
Year 1993
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8233720
Keywords
immunization National Center for Biotechnology Information NCBI NLM MEDLINE Mice animals pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't female Disease Models Animal P.H.S. Antibodies Inbred BALB C evaluation studies as topic in vitro techniques neutralization tests respiratory syncytial virus infections / prevention & control* virus replication passive* respiratory syncytial virus infections / therapy* respiratory syncytial viruses / immunology respiratory syncytial virus infections / pathology b s graham respiratory syncytial viruses / physiology viral / administration & dosage w c gruber pmid:8233720 doi:10.1203/00006450-199308000-00013 t h davis viral / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.